{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:32:27Z","timestamp":1787851947586,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["12133881"],"award-info":[{"award-number":["12133881"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ijbiomac.2018.09.151","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T03:27:38Z","timestamp":1537846058000},"page":"1480-1489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"PB","title":["Lycium barbarum polysaccharides improve hepatic injury through NFkappa-B and NLRP3\/6 pathways in a methionine choline deficient diet steatohepatitis mouse model"],"prefix":"10.1016","volume":"120","author":[{"given":"Jia","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Liong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Fai","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Tipoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijbiomac.2018.09.151_bb0005","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ijbiomac.2018.09.151_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nature reviews. Disease primers"},{"issue":"8","key":"10.1016\/j.ijbiomac.2018.09.151_bb0015","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab. Clin. Exp."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.09.151_bb0020","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.ijbiomac.2018.09.151_bb0025","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMc1006581","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"363","author":"Armstrong","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2018.09.151_bb0030","first-page":"33","article-title":"An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides","volume":"9","author":"Cheng","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"issue":"12","key":"10.1016\/j.ijbiomac.2018.09.151_bb0035","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.4103\/1673-5374.172315","article-title":"Lycium barbarum polysaccharides promotes in vivo proliferation of adult rat retinal progenitor cells","volume":"10","author":"Wang","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ijbiomac.2018.09.151_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2017.06.014","article-title":"Protective effect of Lycium barbarum polysaccharides on dextromethorphan-induced mood impairment and neurogenesis suppression","volume":"134","author":"Po","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ijbiomac.2018.09.151_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2017.02.002","article-title":"Effects of Lycium barbarum on the visual system","volume":"135","author":"Manthey","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2018.09.151_bb0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fncel.2017.00288","article-title":"Neuroprotective mechanisms of Lycium barbarum polysaccharides against ischemic insults by regulating NR2B and NR2A containing NMDA receptor signaling pathways","volume":"11","author":"Shi","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.09.151_bb0055","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jep.2011.11.033","article-title":"Lycium barbarum polysaccharides protect mice liver from carbon tetrachloride-induced oxidative stress and necroinflammation","volume":"139","author":"Xiao","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2018.09.151_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijbiomac.2014.05.034","article-title":"Lycium barbarum polysaccharide attenuates alcoholic cellular injury through TXNIP-NLRP3 inflammasome pathway","volume":"69","author":"Xiao","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.09.151_bb0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1167\/iovs.17-22881","article-title":"Lycium barbarum polysaccharides protect retina in rd1 mice during photoreceptor degeneration","volume":"59","author":"Liu","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.09.151_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3727\/105221617X15093707969658","article-title":"Updates on dietary models of non-alcoholic fatty liver disease: current studies and insights","volume":"18","author":"Stephenson","year":"2018","journal-title":"Gene Expr."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.09.151_bb0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2018.09.151_bb0080","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1159\/000484116","article-title":"LncRNA HANR promotes tumorigenesis and increase of chemoresistance in hepatocellular carcinoma","volume":"43","author":"Xiao","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"7384","key":"10.1016\/j.ijbiomac.2018.09.151_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijbiomac.2018.09.151_bb0090","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.09.151_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1499-3872(13)60021-1","article-title":"Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges","volume":"12","author":"Xiao","year":"2013","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"12","key":"10.1016\/j.ijbiomac.2018.09.151_bb0100","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2174\/1389450116666150531155711","article-title":"Natural products on nonalcoholic fatty liver disease","volume":"16","author":"Xu","year":"2015","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.09.151_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1574887109666141216110337","article-title":"Phytotherapy and NAFLD--from goals and challenges to clinical practice","volume":"9","author":"Milosevic","year":"2014","journal-title":"Rev. Recent Clin. Trials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.09.151_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/toxsci\/kfx253","article-title":"Methionine and choline deficient (MCD) model in predicting adverse drug reactions in human NASH","volume":"161","author":"Li","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.09.151_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-beta in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.09.151_bb0120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2559.2005.02226.x","article-title":"The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study","volume":"47","author":"Akpolat","year":"2005","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.09.151_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","article-title":"Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1, and NF-kappa B pathways","volume":"53","author":"Xiao","year":"2014","journal-title":"Eur. J. Nutr."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.09.151_bb0130","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1039\/C5FO00126A","article-title":"Protective effect of theaflavin-enriched black tea extracts against dimethylnitrosamine-induced liver fibrosis in rats","volume":"6","author":"Weerawatanakorn","year":"2015","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.09.151_bb0135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jep.2012.10.047","article-title":"Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells","volume":"145","author":"Cheng","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2018.09.151_bb0140","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00210-016-1210-1","article-title":"Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators","volume":"389","author":"Algandaby","year":"2016","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2018.09.151_bb0145","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijbiomac.2017.03.024","article-title":"Protective effect of pilose antler peptide on carbon tetrachloride-induced hepatotoxicity in mice","volume":"99","author":"Chunhua","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2018.09.151_bb0150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/gut.2007.134288","article-title":"Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis","volume":"57","author":"Beraza","year":"2008","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.09.151_bb0155","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-kappaB in the liver--linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.09.151_bb0160","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1096\/fj.201700602R","article-title":"Silybin inhibits NLRP3 inflammasome assembly through the NAD+\/SIRT2 pathway in mice with nonalcoholic fatty liver disease","volume":"32","author":"Zhang","year":"2018","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.09.151_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2017.07.011","article-title":"Nlrp6- and ASC-dependent inflammasomes do not shape the commensal gut microbiota composition","volume":"47","author":"Mamantopoulos","year":"2017","journal-title":"Immunity"},{"issue":"6293","key":"10.1016\/j.ijbiomac.2018.09.151_bb0170","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1126\/science.aaf7419","article-title":"A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion","volume":"352","author":"Birchenough","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.09.151_bb0175","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2018.09.151_bb0180","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/00365520903114912","article-title":"Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice","volume":"44","author":"Nan","year":"2009","journal-title":"Scand. J. Gastroenterol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813018309966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813018309966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T14:41:00Z","timestamp":1565275260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813018309966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"alternative-id":["S0141813018309966"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.09.151","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lycium barbarum polysaccharides improve hepatic injury through NFkappa-B and NLRP3\/6 pathways in a methionine choline deficient diet steatohepatitis mouse model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.09.151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}